US Food and Drug Administration
Silver Spring, Maryland
Dr. Nahid Kamal is currently a Research Chemist at the Office of Testing and Research of CDER at FDA. Dr. Kamal is an expert of developing and validating various IVRT and IVPT methods for various topical and transdermal drug products. She has extensive research experience on formulation and Q3 characterization of generic topical drug products such as creams, ointments and hydrogels. Dr. Kamal has made also significant contribution to the agency’s initiative of characterizing the abuse deterrence of opioid drug products. Dr Kamal research has resulted in various peer reviewed journal papers and has been recognized for various FDA awards. Prior joining FDA, she received her Ph.D. in Pharmaceutical Sciences from Long Island University, Brooklyn, New York.